NCT00927277

Low Level Laser Light Therapy as an Aid to Liposuction

Erchonia Medical, Inc., Erchonia EML Laser Liposuction Clinical Study V Protocol

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 70 (actual)
• Sponsor: Erchonia Corporation · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine whether low level laser therapy can help the recovery process for the procedure of liposuction of the thighs, hips and stomach.

Detailed description

The Erchonia EML Laser is designed to administer low level laser therapy (LLLT). It has been hypothesized that LLLT may reduce pain and promote nerve regeneration through the speculated anti-inflammatory and immune enhancement properties of the therapy. Prior research has indicated LLLT to be a potentially safe and effective means of reducing pain. This clinical study was designed to evaluate the potential of the Erchonia EML Laser in offering a novel means of delivering LLLT to reduce pain and enhance healing following liposuction.

Conditions

• Pain

Interventions

Type	Name	Description
DEVICE	Erchonia(R) LipoLASER PL; Erchonia(R) EML Laser	The Erchonia(R) EML Laser is a low level laser light therapy medical device that was applied during the liposuction procedure, by emitting 1 mw of red (635nm wavelength) light via a Class II electric laser diode energy source (CDRH classification). The fluence is considered to be at 10.8 joules per area treated.
DEVICE	Erchonia(R) LipoLASER PL

Timeline

• Start date: 2003-03-01
• Primary completion: 2004-03-01
• Completion: 2004-03-01
• First posted: 2009-06-24
• Last updated: 2009-06-26